Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4199

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 70518-4199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Rosuvastatin 20 mg film-coated tablets in a bottle containing 90 tablets. The label includes the product name, strength, dosage form, quantity, and manufacturer RemedyRepack Inc., with a barcode and QR code present. Directions reference the package insert.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier curve chart showing cumulative incidence percentage over approximately 5 years, comparing Rosuvastatin calcium (Rosuva) and placebo groups. The chart includes hazard ratio data (HR 0.56, 95% CI 0.46-0.69, P<0.001). Below the graph, the number of patients at risk over time for both Rosuvastatin and placebo groups is listed.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A data table presenting clinical trial event rates comparing Rosuvastatin calcium 20 mg to placebo 20 mg in 8901 patients each. The table shows the number of events and event rates per 1000 patient-years for endpoints including primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization, with corresponding hazard ratios, 95% confidence intervals, and p-values. A forest plot visualizes hazard ratios and confidence intervals.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A box-and-whisker plot showing percent change from baseline in LDL-C levels by dose for four statin drugs: Rosuvastatin (10, 20, 40 mg), Atorvastatin (10, 20, 40, 80 mg), Simvastatin (10, 20, 40, 80 mg), and Pravastatin (10, 20, 40 mg). The vertical axis represents percent change from baseline in LDL-C, ranging from 0 to -75%. Each drug's dose groups are visually compared for LDL-C reduction variability and median reduction levels.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Rosuvastatin calcium showing its molecular components including rings, hydroxyl groups, and calcium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.